Labcorp wins FDA approval for PGDx elio tissue complete melanoma companion diagnostic
LH•FDA clearance for melanoma companion diagnostic
Labcorp won FDA clearance for PGDx elio tissue complete CDx as a companion diagnostic for advanced melanoma.
The test identifies BRAF V600E/K variants to guide use of FDA-cleared BRAF inhibitors, including BRAF/MEK combinations.
The kit-based format targets broader adoption across hospitals, expanding access to molecular testing.
